Literature DB >> 22370516

Pandemic influenza hospitalization in Spain (2009): incidence, in-hospital mortality, comorbidities and costs.

Cristina Rodríguez-Rieiro1, Pilar Carrasco-Garrido, Valentín Hernández-Barrera, Ana López de Andrés, Isabel Jimenez-Trujillo, Angel Gil de Miguel, Rodrigo Jiménez-García.   

Abstract

Based on data drawn from the national hospitalization discharge registry, we sought to describe the clinical and epidemiological characteristics of patients hospitalized with pandemic influenza H1N1 in Spain in 2009. Authors calculated national rates of hospitalization stratified by age and analyzed co-morbidities, in hospital mortality, average length of stay and associated medical costs. A total of 11,449 patients were hospitalized (24.9/100,000 inhabitants). Median age was 34 y and 50.28% were male. The highest incidence was observed in the group from 0 to 14 y (42.3/100000 inhabitants), 27.7% of hospitalized women of childbearing age were pregnant and overall in hospital mortality reached 2.46%. The average length of stay was 5 d, median costs per admission was €2,152 and total cost was €35.4 million. Among those patients, 5,791 (50.6%) had an underlying chronic disease: asthma (15.36%), diabetes (9.02%), obesity (8.47%), cancer (4.47%), epilepsy (2.24%), and HIV (2.22%). Suffering a chronic condition was an independent risk factor for dying (OR 13.31 95% for 0-14 y and OR 3.27 for 15-64 y). We conclude that hospitalization was higher in infants and in young adults with associated co-morbidities. Suffering a chronic condition increased the risk of dying as the age decreased. This information will be helpful to prepare vaccination strategies against next pandemic threats.

Entities:  

Mesh:

Year:  2012        PMID: 22370516     DOI: 10.4161/hv.18911

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  8 in total

Review 1.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

2.  Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital.

Authors:  Talita Rantin Belucci; Alexandre R Marra; Michael B Edmond; João Renato Rebello Pinho; Paula Kiyomi Onaga Yokota; Ana Carolina Cintra Nunes Mafra; Oscar Fernando Pavão Dos Santos
Journal:  BMC Infect Dis       Date:  2018-11-16       Impact factor: 3.090

3.  Inpatient hospital fatality related to coding (ICD-9-CM) of the influenza diagnosis in Spain (2009-2015).

Authors:  J M San-Román-Montero; R Gil Prieto; C Gallardo Pino; J Hinojosa Mena; A Zapatero Gaviria; A Gil de Miguel
Journal:  BMC Infect Dis       Date:  2019-08-07       Impact factor: 3.090

4.  Serum IgG Concentrations in Adult Patients Experiencing Virus-Induced Severe Asthma Exacerbations.

Authors:  Morgane Verduyn; Guillaume Botto; Julien Jaubert; Clément Lier; Thomas Flament; Laurent Guilleminault
Journal:  J Allergy Clin Immunol Pract       Date:  2019-01-14

Review 5.  Human Influenza Virus Infections.

Authors:  Christin Peteranderl; Susanne Herold; Carole Schmoldt
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

6.  Cost-effectiveness of emergency preparedness measures in response to infectious respiratory disease outbreaks: a systematic review and econometric analysis.

Authors:  Constantine Vardavas; Katerina Nikitara; Konstantinos Zisis; Konstantinos Athanasakis; Revati Phalkey; Jo Leonardi-Bee; Helen Johnson; Svetla Tsolova; Massimo Ciotti; Jonathan E Suk
Journal:  BMJ Open       Date:  2021-04-29       Impact factor: 2.692

Review 7.  Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.

Authors:  Felix M Reyes; Manuel Hache-Marliere; Dimitris Karamanis; Cesar G Berto; Rodolfo Estrada; Matthew Langston; George Ntaios; Perminder Gulani; Chirag D Shah; Leonidas Palaiodimos
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

Review 8.  Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

Authors:  Hakimeh Baghaei Daemi; Muhammad Fakhar-E-Alam Kulyar; Xinlin He; Chengfei Li; Morteza Karimpour; Xiaomei Sun; Zhong Zou; Meilin Jin
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.